- Business
- Steep Hill Inc. (CSE: STPH) operates as a publicly traded Canadian company with no current significant operations, having previously functioned as a science and technology firm focused on cannabis and hemp markets through analytical testing services, laboratory analysis for potency, terpenes and contaminants, genetics research and development, licensing of intellectual property such as the QuantaCann onsite potency testing systems, remote testing solutions, consulting, and related compliance products for cultivators, processors and dispensaries worldwide. Founded in 2007 and headquartered in Berkeley, California, with subsidiaries including Canbud entities holding industrial hemp licenses and operations spanning Canada and the United States, the company historically targeted the medical, adult-use, healthcare, pharmaceutical and recreational cannabis sectors using advanced equipment like Shimadzu gas chromatography for regulatory contaminant screening, quantitative analysis, microbiological testing, residual solvents and pesticides detection, as well as environmental sampling and data integration platforms. In November 2025, Steep Hill entered into an amalgamation agreement with Good Purpose Investments Inc. and its wholly owned subsidiary to acquire all issued securities of Good Purpose in a reverse takeover transaction classified as a fundamental change under CSE policies, involving a name change to Good Purpose Investments Inc., a 1-for-3 share consolidation, ticker symbol change, board reconstitution, and concurrent financing by Good Purpose of $3 million to $10 million to support its textiles manufacturing from recycled plastics under the Waste2Wear brand; earlier in February 2025, it signed a share purchase agreement for Lir Life Sciences Inc. that would have constituted another reverse takeover but appears superseded by the ongoing Good Purpose deal.